Literature DB >> 12022369

DNA ploidy and cytonuclear area of peritumoral and paratumoral samples of mastectomy specimens: a useful prognostic marker?

Elisabeth M Chávez-Uribe1, Juan E Viñuela, José Cameselle-Teijeiro, Jerónimo Forteza, José A Puñal, José L Otero, José L Puente-Dominguez.   

Abstract

OBJECTIVE: To investigate a possible relationship between DNA alterations in the "normal" residual mammary tissue of patients with breast cancer and survival.
DESIGN: Prospective study.
SETTING: University hospital, Spain.
SUBJECTS: 162 patients operated on for breast cancer between 1991 and 1995. MAIN OUTCOME MEASURES: Cytology, histopathology, optic karyometry, DNA ploidy, and S-phase fraction measured by flow cytometry in peritumoral and paratumoral tissue. Mortality, and univariate analysis.
RESULTS: DNA ploidy in peritumoral tissue was altered in 42 patients (26%), in 41 of whom the mean cytonuclear area was also altered. Of the 19 patients whose death within the study period was attributed to their cancer, 13 had peritumoral tissue in which both DNA ploidy and mean cytonuclear area were altered. On univariate analysis, there was significantly worse survival among the patients in whom both tumoral and peritumoral tissues were DNA aneuploid than among those in whom only tumoural tissue was DNA aneuploid (p < 0.0001).
CONCLUSIONS: The presence of peritumoral or paratumoral tissue or both, with anomalous DNA content is associated with a reduced survival among women whose breast cancer has been treated by mastectomy. Additional studies including multivariate analysis are necessary to confirm our findings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022369     DOI: 10.1080/110241502317307553

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  2 in total

1.  Serum sFas and tumor tissue FasL negatively correlated with survival in Egyptian patients suffering from breast ductal carcinoma.

Authors:  Ashgan I El-Sarha; Gehan M Magour; Sameh M Zaki; Mohamed Y El-Sammak
Journal:  Pathol Oncol Res       Date:  2008-11-18       Impact factor: 3.201

2.  Family history and breast cancer hormone receptor status in a Spanish cohort.

Authors:  Xuejuan Jiang; Jose Esteban Castelao; Elisabet Chavez-Uribe; Beatriz Fernandez Rodriguez; Catuxa Celeiro Muñoz; Carmen M Redondo; Maite Peña Fernandez; Alejandro Novo Dominguez; Carina Doris Pereira; María Elena Martínez; Tomás García-Caballero; Máximo Fraga Rodriguez; José Antúnez; Angel Carracedo; Jerónimo Forteza-Vila; Manuela Gago-Dominguez
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.